2023
DOI: 10.1016/j.addr.2022.114621
|View full text |Cite
|
Sign up to set email alerts
|

Image-guided drug delivery in nanosystem-based cancer therapies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(4 citation statements)
references
References 242 publications
0
4
0
Order By: Relevance
“…86 Particularly, the development of tumor-specific activated fluorescent probes meets the need for real-time feedback during tumor treatment. 87 In Zhang's design, the engineering of a GSH-labile near-infrared (NIR) CPT prodrug nanoplatform for fluorescence imaging in tumor therapy was developed. 88 In this study, the NIR prodrug POEGMA- b -P(CPT-CyOH) ( PCC ) was firstly synthesized, which could self-assemble in water to produce the PCC micelle-based nanoprodrugs for in vivo delivery of the NIR probe CyOH and therapeutic drug CPT (Fig.…”
Section: Reduction-responsive Cpt Prodrug Nanomedicinesmentioning
confidence: 99%
“…86 Particularly, the development of tumor-specific activated fluorescent probes meets the need for real-time feedback during tumor treatment. 87 In Zhang's design, the engineering of a GSH-labile near-infrared (NIR) CPT prodrug nanoplatform for fluorescence imaging in tumor therapy was developed. 88 In this study, the NIR prodrug POEGMA- b -P(CPT-CyOH) ( PCC ) was firstly synthesized, which could self-assemble in water to produce the PCC micelle-based nanoprodrugs for in vivo delivery of the NIR probe CyOH and therapeutic drug CPT (Fig.…”
Section: Reduction-responsive Cpt Prodrug Nanomedicinesmentioning
confidence: 99%
“…However, noncovalent encapsulation has been criticized for its poor stability, low drug delivery efficiency, and premature leakage of drug or uorescent dye in the systemic circulation. 12,13 Consequently, these issues urge us to develop a particular visualized prodrug to improve metabolic stability and real-time monitoring of drug location.…”
Section: Introductionmentioning
confidence: 99%
“…To confront these challenges, researchers from different disciplines, including therapeutics, chemistry, materials science, and pharmacology, have collaborated closely to apply nanosystems to cancer therapies 7–10 . Nanosystems within the dimensions of 1 to 100 nm have been proposed for their minimal invasiveness, high effectiveness, and efficient drug delivery 11–13 . Several variants of nano‐drug delivery systems have been successfully studied for therapeutic applications, such as liposomes, dendrimers, polymeric nanoparticles, nanoemulsions, carbon nanotubes, gold nanoparticles, magnetic nanoparticles, solid lipid nanoparticles, hydrogels, and micelles 2 .…”
Section: Introductionmentioning
confidence: 99%
“… 7 , 8 , 9 , 10 Nanosystems within the dimensions of 1 to 100 nm have been proposed for their minimal invasiveness, high effectiveness, and efficient drug delivery. 11 , 12 , 13 Several variants of nano‐drug delivery systems have been successfully studied for therapeutic applications, such as liposomes, dendrimers, polymeric nanoparticles, nanoemulsions, carbon nanotubes, gold nanoparticles, magnetic nanoparticles, solid lipid nanoparticles, hydrogels, and micelles. 2 More importantly, some nanosystems could be developed to include extra therapy functions, like photothermal therapy (PTT).…”
Section: Introductionmentioning
confidence: 99%